# FDA Warning Letter: Jamol Laboratories, Inc.
> 2023-08-01 · Division of Pharmaceutical Quality Operations I · `b2794dfb30ea1d39`
## Letter
- **Company:** Jamol Laboratories, Inc.
- **Posted Date:** 2023-08-01
- **Letter Issue Date:** 2023-07-13
- **Issuing Office:** Division of Pharmaceutical Quality Operations I
## Subject
CGMP/Finished Pharmaceuticals/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*